EUVIMEDEUVIMED entdecken
Crossref

Integrating patient-derived organoids and multi-omics to decode spatiotemporal therapeutic resistance

Cize Gao, Jianing Chen, Leilei Wu, Boyue Pang, Chunxia Su

Organoid Research · 09.03.2026 · 2 (1) · 026020002

DOI: 10.36922/or026020002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Organoid Research, online erschienen am 09.03.2026. Verfasst von Cize Gao und 4 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Intratumoral heterogeneity, alongside the dynamic evolution of cancer cells, continues to pose principal obstacles to efficacious cancer therapies. Although patient-derived organoids (PDOs) represent the gold standard for recapitulating patient-specific histopathology, their full utility emerges only through integration with high-resolution molecular profiling. This review synthesizes recent progress in combining PDOs with multi-omics approaches—including genomics, single-cell transcriptomics, and spatial omics—to elucidate the underpinnings of therapeutic resistance. We initially explore how organoid genomic profiling can monitor clonal dynamics and subclonal selection under therapeutic pressure. Next, we underscore the contributions of single-cell RNA sequencing in delineating transcriptional plasticity, detecting infrequent drug-tolerant persister populations, and charting nongenetic adaptive pathways. Of particular importance, we address the nascent domain of spatial transcriptomics, which preserves the structural integrity of organoids to uncover how proximate cell–cell interactions and niche elements shield tumor cells from therapeutic insult. Through the fusion of these multifaceted datasets, we advance a novel paradigm that frames resistance not as a fixed binary state, but as a spatiotemporally evolving adaptive phenomenon. The review culminates in delineating the translational promise of this synergistic paradigm for devising combination regimens that concurrently address genetic aberrations and adaptive microenvironments.

Zitieren

APA

Gao, C., Chen, J., Wu, L., Pang, B., & Su, C. (2026). Integrating patient-derived organoids and multi-omics to decode spatiotemporal therapeutic resistance. Organoid Research, 2(1), 026020002. https://doi.org/10.36922/or026020002

Vancouver

Gao C, Chen J, Wu L, Pang B, Su C. Integrating patient-derived organoids and multi-omics to decode spatiotemporal therapeutic resistance. Organoid Research. 2026;2(1):026020002. doi:10.36922/or026020002

BibTeX
@article{Gao2026,
  author = {Gao, Cize and Chen, Jianing and Wu, Leilei and Pang, Boyue and Su, Chunxia},
  title = {Integrating patient-derived organoids and multi-omics to decode spatiotemporal therapeutic resistance},
  journal = {Organoid Research},
  year = {2026},
  volume = {2},
  number = {1},
  pages = {026020002},
  doi = {10.36922/or026020002}
}
Kostenlos starten →